Review of fecal biomarkers in inflammatory bowel disease

Diseases of the Colon and Rectum

Volumn 51, Issue 8, 2008, Pages 1283-1291

  Sutherland, Andrew D ^a   Gearry, Richard B ^a   Frizelle, Frank A ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Biomarkers; Calprotectin; Crohn's disease; Inflammatory bowel disease; Lactoferrin; Ulcerative colitis

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; CALGRANULIN; ELASTASE; EOSINOPHIL CATIONIC PROTEIN; INDIUM 111; LACTOFERRIN; LIPOCALIN; LYSOZYME; MYELOPEROXIDASE; PROTEIN X;

ABDOMINAL PAIN; ANASTOMOSIS; CELIAC DISEASE; COLITIS; COLLAGENOUS COLITIS; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE ACTIVITY; DIVERTICULOSIS; ENTERITIS; FECES; GRANULOCYTE; HUMAN; ILEUM POUCH; IRRITABLE COLON; ISOTOPE LABELING; LABORATORY TEST; LEUKOCYTE; PROTEIN FUNCTION; RECURRENCE RISK; REVIEW; RISK FACTOR; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; LACTOFERRIN; LEUKOCYTE L1 ANTIGEN COMPLEX;

EID: 48349137880     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9310-8     Document Type: Review

References (56)

1. D Desai WA Faubion WJ Sandborn 2007 Review article: biological markers in inflammatory bowel disease Aliment Pharmacol Ther 25 247 255
2. I Angriman M Scarpa R D'Incà 2007 Enzymes in feces: useful markers of chronic inflammatory bowel disease Clin Chim Acta 381 63 68
3. HJ Klass G Neale 1978 Serum and fecal lysozyme in inflammatory bowel disease Gut 19 233 239
4. J Langhorst S Elsenbruch T Mueller 2005 Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis Inflamm Bowel Dis 11 1085 1091
5. T Saiki 1998 Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease Kurume Med J 45 69 73
6. EO Adeyemi HJ Hodgson 1992 Fecal elastase reflects disease activity in active ulcerative colitis Scand J Gastroenterol 27 139 142
7. A van der Sluys Veer J Brouwer I Biemond 1998 Fecal lysozyme in assessment of disease activity in inflammatory bowel disease Dig Dis Sci 43 590 595
8. H Silberer B Kuppers O Mickisch 2005 Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome Clin Lab 51 117 126
9. CG Peterson E Eklund Y Taha Y Raab M Carlson 2002 A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease Am J Gastroenterol 97 1755 1762
10. L Biancone M Fantini C Tosti 2003 Fecal alpha-1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum European J Gastroenterol Hepatol 15 261 266
11. CP Choudari S O'Mahony G Brydon O Mwantembe A Ferguson 1993 Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease Gastroenterology 104 1064 1071
12. SH Saverymuttu M Camilleri H Rees 1986 Indium-111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease: a comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion Gastroenterology 90 1121 1128
13. AG Røseth PN Schmidt MK Fagerhol 1999 Correlation between fecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease Scand J Gastroenterol 34 50 54
14. J Tibble K Teahon B Thjodleifsson 2000 A simple method for assessing intestinal inflammation in Crohn's disease Gut 47 506 513
15. R D'Incà E Dal Pont V Di Leo 2007 Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease Int J Colorectal Dis 22 429 437
16. A Bremner S Roked R Robinson I Phillips M Beattie 2005 Fecal calprotectin in children with chronic gastrointestinal symptoms Acta Paediatr 94 1855 1858
17. AG Røseth E Aadland J Jahnsen N Raknerud 1997 Assessment of disease activity in ulcerative colitis by fecal calprotectin, a novel granulocyte marker protein Digestion 58 176 180
18. AG Røseth MK Fagerhol E Aadland H Schjønsby 1992 Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study Scand J Gastroenterol 27 793 798
19. SV Kane WJ Sandborn PA Rufo 2003 Fecal Lactoferrin is a sensitive and specific marker in identifying intestinal inflammation Am J Gastroenterol 98 1309 1314
20. K Sugi O Saitoh I Hirata K Katsu 1996 Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins Am J Gastroenterol 91 927 934
21. K Uchida R Matsuse S Tomita O Sugi 1994 Immunochemical detection of human lactoferrin in feces as a new marker of inflammatory gastrointestinal disorders and colon cancer Clin Biochem 27 259 264
22. BB Grill AC Hillemeier JD Gryboski 1984 Fecal alpha-1-antitrypsin clearance in patients with inflammatory bowel disease J Pediatr Gastroenterol Nutr 3 56 61
23. A van der Sluys Veer I Biemond HW Verspaget CB Lamers 1999 Fecal parameters in the assessment of activity of inflammatory bowel disease Scand J Gastroenterol 34 Suppl 230 106 110
24. S Meyers A Wolke SP Field 1985 Fecal alpha-1-antitrypsin measurement: An indicator of Crohn's disease activity Gastroenterology 89 13 18
25. AW Segal J Ensell JA Munro M Sarner 1981 Indium-111-tagged leukocytes in the diagnosis of inflammatory bowel disease Lancet ii 230 232
26. SH Saverymuttu AM Peters ME Crofton 1985 111 Indium labelled autologous granulocytes in the detection of inflammatory bowel disease Gut 26 955 960
27. Saverymuttu SH, Hodgson HJ, Chadwick VS. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis. Dig Dis Sci 1984;29:1000-4.
28. M Steinbakk C-F Naess-Andresen E Lingaas 1990 Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin Lancet 336 763 765
29. MK Fagerhol I Dale I Anderson 1980 Release and quantification of leukocyte derived protein (L1) Scand J Haematol 24 393 398
30. H Ton O Brandnes S Dale 2000 Improved assay for fecal calprotectin Clin Chim Acta 292 41 54
31. S Buderus J Boone D Lyerly MJ Lentze 2004 Fecal lactoferrin: a new parameter to monitor infliximab therapy Digestive Dis Sci 49 1036 1039
32. MA Parsi B Shen JP Achkar 2004 Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis Gastroenterology 126 1280 1286
33. JJ Bernier C Florent C Desmazures C Aymes C L'Hirondel 1978 Diagnosis of protein losing enteropathy by gastrointestinal clearance of alpha-1-antitrypsin Lancet 2 763 764
34. C Florent C L'Hirondel C Desmazures V Giraudeaux JJ Bernier 1981 Evaluation of ulcerative colitis and Crohn's disease activity by measurement of alpha-1-antitrypsin intestinal clearance Gastroenterol Clin Biol 5 193 197
35. JO Lundberg PM Hellström MK Fagerhol E Weitzberg AG Røseth 2005 Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease Gastroenterol Hepatol 2 96 102
36. JO Lundberg PM Hellström JM Lundberg K Alving 1994 Greatly increased luminal nitric oxide in ulcerative colitis Lancet 344 1673 1674
37. A Perner I Nordgaard P Matzen J Rask-Madsen 2002 Colonic production of nitric oxide gas in ulcerative colitis, collagenous colitis and uninflamed bowel Scand J Gastroenterol 37 183 188
38. WG Thompson GF Longstreth DA Drossman 1999 Functional bowel disorders and functional abdominal pain Gut 45 Suppl 2 II43 II47
39. JA Tibble G Sigthorsson R Foster 2002 Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease Gastroenterology 123 450 460
40. RB Canani LT de Horatio G Terrin 2006 Combined use of non-invasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease J Pediatr Gastroenterol Nutr 42 9 15
41. A Carroccio G Iacono M Cottone 2003 Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children Clin Chem 49 861 867
42. AC von Roon L Karamountzos S Purkayastha 2007 Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy Am J Gastroenterol 102 803 813
43. S Dolwani M Metzner JJ Wassell A Yong AB Hawthorne 2004 Diagnostic accuracy of fecal calprotectin estimation in prediction of abnormal small bowel radiology Aliment Pharmacol Ther 20 615 621
44. J Tibble G Sigthorsson R Foster 2001 Fecal calprotectin and fecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma Gut 49 402 408
45. G Hoff T Grotmol E Thiis-Evensen 2004 Testing for fecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT) Gut 53 1329 1333
46. A Poullis R Foster A Shetty MK Fagerhol MA Mendall 2004 Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk Cancer Epidemiol Biomarkers Prev 13 279 284
47. UL Fagerberg L Lööf U Myrdal L-O Hansson Y Finkel 2005 Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms J Pediatr Gastroenterol Nutr 40 450 455
48. UL Fagerberg L Lööf RD Merzoug L-O Hansson Y Finkel 2003 Fecal calprotectin levels in healthy children studied with an improved assay J Pediatr Gastroenterol Nutr 37 468 472
49. JA Tibble I Bjarnason 2001 Non-invasive investigation of inflammatory bowel disease World J Gastroenterol 7 460 465
50. AG Røseth E Aadland K Grzyb 2004 Normalization of fecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease Scand J Gastroenterol 39 1017 1020
51. P Gomes C Du Bolay CL Smith G Holdstock 1986 Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease Gut 27 92 95
52. JA Tibble G Sigthorsson S Bridger MK Fagerhol I Bjarnason 2000 Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease Gastroenterology 119 15 22
53. F Costa MG Mumolo L Ceccarelli 2005 Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease Gut 54 364 368
54. M Scarpa R D'Inca D Basso 2007 Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease Dis Colon Rectum 50 861 869
55. MA Parsi JJ Ellis BA Lashner 2004 Cost-effectiveness analysis of fecal lactoferrin assay as the initial diagnostic approach to symptomatic patients with ileal pouch-anal anastomosis Gastroenterology 128 Suppl 2 A208
56. P Thomas H Rihani A Røseth 2000 Assessment of ileal pouch inflammation by single stool calprotectin assay Dis Colon Rectum 43 214 220